 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 描述 | MKT-077 (FJ-776), a highly water-soluble mitochondrial dye, demonstrates significant antitumor activity[1]. MKT-077 displays low cytotoxicity, inhibiting a wide range of human cancer cell lines including colon cancer, breast cancer, and pancreatic cancer. It also impedes tumor growth in a nude mice engraftment tumor model. Its excitation/emission wavelengths are 488/543 nm[2]. | 
| 体内研究 | Systemic administration of MKT-077 effectively retards the growth of TT xenografts in mice throughout treatment. At the conclusion of MKT-077 treatment, tumor weights are approximately halved compared to the control group. However, MKT-077 treatment also leads to weight loss and general toxicity in animals[1]. Results reveal that the succinate-induced, ADP-stimulated respiratory rate in mitochondria isolated from the livers of rats treated with a bolus i.v. injection of 15 mg MKT-077 per kg body weight each day for 5 days is significantly lower than that of untreated controls[3]. | 
| Concentration | Treated Time | Description | References | |
| MCF-7/TAM-R | 0.1–100 µM | 48 h | To evaluate the cytotoxicity of MKT-077 in breast cancer cells and its synergy with tamoxifen. | Breast Cancer Res. 2024 Feb 26;26(1):33. | 
| T47D/TAM-R | 0.1–100 µM | 48 h | To evaluate the cytotoxicity of MKT-077 in breast cancer cells and its synergy with tamoxifen. | Breast Cancer Res. 2024 Feb 26;26(1):33. | 
| Huh7.5 cells | 0.5, 1, and 5 µM | 48 h | MKT077 significantly reduced the production of infectious ZIKV particles, with a 3-log reduction in viral titre for pre-treatment and a 4-log reduction for post-treatment samples. | Emerg Microbes Infect. 2019;8(1):8-16. | 
| HeLa cells | 0.35-1.2 μM | 24 h | MKT-077 promotes the clearance of hyperphosphorylated tau in a dose-dependent manner. | J Mol Biol. 2011 Aug 19;411(3):614-32. | 
| leukemic clam hemocytes (LCH) | 1 to 7 μM | 6 to 8 h | disruption of mortalin/p53 binding and translocation of some p53 to the nuclei of cells treated with MKT-077 | Am J Pathol. 2006 May;168(5):1526-30. | 
| A375 cells | 10 μM | 24 h | Evaluate the effect of MKT-077 on apoptosis and autophagy. Results showed that MKT-077 significantly inhibited autophagy, evidenced by SQSTM1 accumulation and increased LC3 II levels. | Cancer Biol Ther. 2014 Feb;15(2):194-9. | 
| H1299 cells | 10 μM | 24 h | Evaluate the effect of MKT-077 on apoptosis and autophagy. Results showed that MKT-077 significantly inhibited autophagy, evidenced by SQSTM1 accumulation and increased LC3 II levels. | Cancer Biol Ther. 2014 Feb;15(2):194-9. | 
| MZ-CRC-1 cells | 0.1 to 10 μM | 48 h | MKT-077 suppressed MZ-CRC-1 cell viability at higher doses with an IC50 of 11.4 μM, primarily inducing cell cycle arrest rather than cell death | Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603. | 
| TT cells | 0.1 to 10 μM | 48 h | MKT-077 significantly reduced TT cell viability with an IC50 of 0.74 μM, inducing cell cycle arrest and cell death | Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603. | 
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | TT cell xenograft model | Intraperitoneal injection | 10 mg/kg | Every 2 days, total 10 doses | MKT-077 significantly suppressed the growth of TT xenografts, reducing tumor weight by approximately two-fold | Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 2.31mL 0.46mL 0.23mL | 11.57mL 2.31mL 1.16mL | 23.15mL 4.63mL 2.31mL | |
| CAS号 | 147366-41-4 | 
| 分子式 | C21H22ClN3OS2 | 
| 分子量 | 432.0 | 
| SMILES Code | O=C1N(CC)/C(S/C1=C2SC3=CC=CC=C3N\2C)=C/C4=CC=CC=[N+]4CC.[Cl-] | 
| MDL No. | MFCD00953420 | 
| 别名 | FJ-776 | 
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C | 
| 溶解方案 | DMSO: 55 mg/mL(127.31 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1